20 Future Polish HealthTech and MedTech Leaders

Nelson Advisors
2 hours ago
14 min read

The Polish healthcare technology ecosystem has transitioned from a localised secondary market into a primary driver of European deep-tech innovation as of the first quarter of 2026. This transformation is underpinned by a structural shift from traditional software development to the application of advanced artificial intelligence, multimodal biological simulations, and high-precision medical hardware.

Currently, Poland hosts over 3,300 active startups, with the Warsaw and Kraków hubs serving as the principal gravity centers for venture activity and technical talent. The sector's expansion is validated by significant capital inflows; in 2025, venture capital investment reached approximately PLN 3.4 Billion (~EUR 800 Million) across 180 distinct transactions, a momentum that has rallied into the current fiscal year.

The institutional backbone of this growth is reinforced by the launch of "Future Tech Poland," a €350 Million fund-of-funds initiative spearheaded by the European Investment Fund (EIF) and Bank Gospodarstwa Krajowego (BGK). This program provides critical liquidity for high-tech ventures at various stages of growth, emphasizing the Polish government’s commitment to establishing the nation as a global tech hub and enhancing the competitiveness of the European Union’s fifth-largest economy. Within this fertile landscape, a cadre of twenty leaders and their respective organizations have emerged as the vanguard of the Polish HealthTech and MedTech renaissance.

The Pillars of Digital Health Infrastructure

The first category of leadership focuses on the foundational layers of the medical experience, scheduling, triage, and data interoperability. These figures have successfully navigated the transition from initial digital adoption to building core infrastructure that integrates directly into the global healthcare stack.

1. Mariusz Gralewski and the DocPlanner Global Network

Mariusz Gralewski, the founder and CEO of DocPlanner, remains the preeminent figure in the Polish digital health landscape. Since its inception in 2012, DocPlanner has evolved from a simple doctor-review platform (ZnanyLekarz) into a global digital health network that links millions of patients with medical professionals across multiple continents. Gralewski’s strategic vision focused on international market expansion, leading to the acquisition of platforms such as Doctoralia, MioDottore and ClinicCloud, thereby creating a unified ecosystem for patient management.

As of late 2024, the DocPlanner group reported over 30 million monthly unique visitors and nearly 5 million monthly appointments managed through its various interfaces. The company’s financial trajectory, characterised by a total raise exceeding $240 million and a recent Series E valuation, positions it as a veteran leader in the Polish unicorn landscape.

Gralewski's impact extends beyond mere scheduling; by centralising patient data and doctor-patient interactions, he has established a standardised digital layer that reduces administrative friction for over 1,300 employees and thousands of clinical partners worldwide.

2. Piotr Orzechowski and the AI Triage Standard at Infermedica

Piotr Orzechowski, through Infermedica, has pioneered the use of artificial intelligence in medical triage and clinical decision support. The "computer brain" developed under his leadership serves as a diagnostic engine that guides patients and clinicians through the complexities of health symptomatic analysis. Infermedica’s B2B SaaS model has gained international traction, notably through a strategic partnership with Microsoft and successful expansion into the German and U.S. markets.

In 2022, the company secured $30 million in Series B funding led by investors such as Karma Ventures and Inovo Venture Partners, reflecting a deep industry confidence in its AI-native architecture. Orzechowski’s focus on integrating smart programs into the quiet "background" of hospital routines allows clinics to improve patient visit quality without disrupting existing workflows. This focus on non-intrusive integration is a key characteristic of the second-order evolution in Polish HealthTech, where technology is seen as a supportive partner rather than a disruptive burden to the clinician.

3. Robert Lugowski and the Real-Time Data Revolution of CliniNote

Robert Lugowski, as CEO of CliniNote, addresses one of the most persistent bottlenecks in modern healthcare: the structuring and utilization of clinical data. Founded in 2020, CliniNote utilizes Natural Language Processing (NLP) to "unlock" the power of clinical data by structuring it in real-time as medical professionals enter notes into existing Hospital Information Systems (HIS) and Electronic Health Records (EHR). This innovation addresses the massive inefficiencies in clinical data management, which traditionally require manual processing and significant administrative time.

The CliniNote platform, developed in collaboration with clinicians from the National Institute of Oncology in Warsaw, includes modules like the CliniNote Assistant and DataCollector, which are designed to support pharmaceutical companies and Contract Research Organizations (CROs). The company’s strategic growth was accelerated by its 2023 funding round led by Sunfish Partners, enabling its solutions to be implemented in major European projects such as Idea4RC and DigiOne. Lugowski’s leadership represents a critical shift toward data-driven decision-making, where the "exhaust" of clinical encounters is converted into high-quality, interoperable data for research and drug development.

4. Marta Lacka and the Strategic Data Insights of Quantia

While many HealthTech founders focus on the patient-provider interaction, Marta Lacka, CEO and founder of Quantia, addresses the data visibility gap for consumer healthcare brands. Quantia is an AI-driven e-commerce data platform that provides real-time insights into market dynamics, including product availability, pricing, and sales performance for enterprise-level retail and health brands such as Nespresso and Procter & Gamble.

In May 2024, Quantia secured $1.2 Million in pre-seed funding led by Inovo.vc and Team X. Lacka’s leadership is defined by her "enterprise-first" background, allowing Quantia to compress strategic planning cycles that typically take ten working days into just 3-5 minutes. By ensuring that both brands and retailers have equal access to performance data, Quantia drives category growth and ensures the right medical and wellness products are available to consumers when needed.

DeepTech and the Future of Pharmaceutical Simulation

The second tier of Polish leadership operates at the intersection of biology and computation, aiming to resolve the high failure rates and astronomical costs associated with traditional drug development and synthesis.

5. Piotr Surma and the Generative Simulation of Ingenix.ai

Piotr Surma, co-founder and CEO of Ingenix.ai, is perhaps the most prominent representative of the "AI-native" wave in Polish MedTech. Surma, who previously co-founded Applica (an AI firm acquired by Snowflake), launched Ingenix in 2023 alongside Adam Dancewicz to address the 90% failure rate of pilot drugs. The startup recently secured €9 Million in seed funding, led by Inovo.vc with participation from OTB Ventures and the IFC—to develop a multimodal generative AI co-pilot that simulates clinical trials with unprecedented granularity.

The Ingenix platform utilizes "digital twins" and is trained on diverse multimodal datasets, including genomic, transcriptomic, and imaging inputs. By simulating biological processes from the molecular level through cellular, tissue, and population-level analysis, the system predicts clinical endpoints and potential adverse events before a physical trial begins.

Surma’s vision is to make the drug development process predictable, potentially delivering the "GPT moment" for the pharmaceutical sector and significantly reducing the $50 billion annual global investment in clinical trials.

6. Piotr Byrski and the Retrosynthesis AI of Molecule.one

Piotr Byrski and Paweł Włodarczyk-Pruszyński, founders of Molecule.one, identified a fundamental bottleneck in drug discovery: the manufacturing feasibility of hypothetical compounds. Molecule.one’s proprietary AI uses retrosynthesis to identify cost-efficient and chemically sound pathways for synthesising new compounds, effectively working backward from a desired molecule to available elements.

Founded in 2016 during the founders' medical studies in Warsaw, Molecule.one closed a $4.6 million seed round in 2021.The company’s SaaS model provides pharmaceutical companies with predictive informatics that suggest optimal reaction conditions and score hypothetical synthesis pathways. By unlocking "digital chemistry," Byrski’s team allows for the exploration of previously inaccessible structures, accelerating the development of innovative drugs to meet emerging health challenges.

Startup	Leader	Core Innovation	Key Funding / Investors
Ingenix.ai	Piotr Surma	Multimodal AI simulations for clinical trials	€9M Seed / Inovo.vc, OTB, IFC
Molecule.one	Piotr Byrski	AI-driven retrosynthesis and drug discovery	$4.6M Seed / Atmos Ventures, Sunfish Partners
CliniNote	Robert Lugowski	Real-time NLP for medical data structuring	Seed / Sunfish Partners
Quantia	Marta Lacka	AI e-commerce analytics for health brands	$1.2M Pre-Seed / Inovo.vc, Team X

Cardiovascular Innovation and High-Precision Hardware

Hardware-enabled medical technology in Poland is witnessing a resurgence, led by founders who combine surgical experience with advanced materials science.

7. Professor Paweł Buszman and the i4hv Longevity Initiative

The startup i4hv, led by interventional cardiologists including Professor Paweł Buszman (Medical Director) and Dr. Piotr Hirnle, is developing a biological heart valve with a significantly extended lifespan. Standard biological valves typically last 10–15 years, necessitating repeat high-risk surgeries for patients over their lifetime. i4hv’s innovation uses polymer or transgenic biological materials to extend this lifespan to 20–30 years.

The project, which received over PLN 30 Million in funding from the European Funds for a Modern Economy (FENG), focuses on Transcatheter Aortic Valve Implementation (TAVI). This minimally invasive, percutaneous therapy is traditionally reserved for older patients; however, i4hv’s long-lasting valves aim to make the procedure accessible to younger patients in their 40s and 50s, allowing them to maintain active lives without the threat of frequent repeat surgeries.

8. Dr. Honorata Hafke and the Remote Diagnostics of StethoMe

Dr. Honorata Hafke founded StethoMe to bridge the gap between home-based monitoring and professional diagnostic accuracy. StethoMe has developed a wireless, AI-powered stethoscope that enables parents and patients to conduct lung and heart examinations from home. The device identifies abnormalities in breath sounds and provides immediate feedback through a consumer-friendly interface, while also sharing high-quality audio data with medical professionals for remote triage.

StethoMe’s trajectory is defined by its partnerships with tech giants like Amazon Web Services and Nvidia, which support its AI development. Having secured $2.5 million in Series A funding from investors like TDJ Pitango Ventures and Movens VC, StethoMe represents a shift toward "decentralised diagnostic hubs" that alleviate the burden on paediatric and primary care clinics.

The Rise of the Polish Femtech Sector

Femtech has emerged as a particularly high-growth vertical in Poland, with fifteen innovative startups identified as changing the landscape of women's health through AI, specialised hardware, and community-driven care.

9. Michał Matuszewski and the AILIS Breast Health System

Michał Matuszewski is the originator and CEO of AILIS, which has developed the world's first AI-powered breast health monitoring capsule. The system uses Parametric Dynamic Imaging (PDI) to distinguish areas of increased activity from normal tissue, identifying cancerous lesions at a very early stage where the recovery rate is up to 99%. Matuszewski’s vision centers on a "fee-for-health" model, transitioning breast screening from hospitals to accessible locations like shopping malls and offices.

AILIS's methodology is non-invasive, radiation-free, and painless, allowing for frequent examinations without the health risks associated with traditional mammography. The company has collaborated with more than 100 experts over seven years and is currently conducting clinical trials with the National Oncology Institute in Kraków. The design of the AILIS capsule, which won the Red Dot Award, emphasizes a "woman-centric" sensory experience to reduce the psychological stress associated with medical screenings.

10. Ula Sankowska and the IVF Optimization at MIM Fertility

Ula Sankowska and PhD Piotr Wygocki founded MIM Fertility to revolutionize the reproductive medicine sector using artificial intelligence. The startup’s software platforms, EMBRYOAID and FOLLISCAN, assist IVF doctors and embryologists by automating the grading of embryos and the measurement of ovarian follicles. These tools significantly increase success rates while reducing the time and costs associated with fertility procedures.

MIM Fertility originated from the Faculty of Mathematics, Informatics, and Mechanics at the University of Warsaw, highlighting the critical link between academic research and commercial MedTech in Poland. In December 2023, the startup raised $2 million in seed funding from Tangent Line and Peleton to expand its global presence. Their recent research presented at ASRM 2025 demonstrates that their AI models match the accuracy of expert sonographers in follicle measurement, validating the clinical utility of their algorithms.

11. Kaja Rybicka-Gut and the Transparency of Your KAYA

Kaja Rybicka-Gut, co-founder of Your KAYA, has led the charge in the organic intimate health and care sector. Your KAYA operates on a subscription model, offering organic cotton menstrual products that emphasize health safety and environmental sustainability. While categorised as an e-commerce brand, Rybicka-Gut has used the platform to build a comprehensive wellness ecosystem that provides education on women's health, representing the intersection of HealthTech and consumer empowerment.

12. Aleksandra Staniszewska and the Precision of My OVU

Aleksandra Staniszewska is the creator of My OVU, an innovative ovulation thermometer that utilizes a vaginal silicone disc for precise cycle monitoring. By combining specialized hardware with an AI-integrated app, My OVU provides women with accurate data on fertile days and overall hormonal health. This approach reflects the broader trend of "miniaturized medical labs" where hardware-software integration allows for diagnostic-level monitoring outside of clinical settings.

13. Karolina Szymczak-Adamczyk and the EndoMe Community

Karolina Szymczak-Adamczyk founded EndoMe to support women struggling with endometriosis, drawing from her decade-long struggle with the disease. EndoMe combines a supplement brand with a supportive community, addressing the holistic needs of patients who often face long diagnostic delays and inadequate support in traditional health systems. Szymczak-Adamczyk’s leadership highlights the importance of "patient-led innovation," where lived experience dictates the design of health solutions.

Femtech Startup	Leader	Focus Area	Technology / Approach
AILIS	Michał Matuszewski	Breast Cancer Detection	Parametric Dynamic Imaging (PDI) + AI
MIM Fertility	Ula Sankowska	Infertility Treatment	EMBRYOAID (Embryo grading) + FOLLISCAN
My OVU	Aleksandra Staniszewska	Fertility Monitoring	Vaginal silicone disc + AI app
EndoMe	Karolina Szymczak-Adamczyk	Endometriosis Support	Specialized supplements + Community
Your KAYA	Kaja Rybicka-Gut	Intimate Care	Subscription-based organic products

Primary Care, Wellness and Mental Health

A new generation of Polish HealthTech leaders is redefining the "front door" of healthcare, moving beyond episodic treatment to continuous wellness management and integrated primary care.

14. Adam Janczewski and the Hybrid Model of Jutro Medical

Adam Janczewski, founder of Jutro Medical, has pioneered a hybrid model that combines advanced digital

triage with a network of modern physical clinics. Founded in 2020, Jutro Medical aims to revolutionise primary healthcare (POZ) accessibility in Poland by automating administrative tasks and offering seamless telemedicine integrations.

In 2024, the startup secured debt financing from mBank to fuel its physical expansion. Janczewski’s model addresses the chronic underfunding and administrative bloat of traditional primary care, offering a blueprint for a more efficient, patient-centred public-private health integration.

15. Dominik Swadzba and the Diagnostic Access of uPacjenta

Dominik Swadzba founded uPacjenta in 2021 to promote preventive laboratory testing among Poles. The company utilizes a B2B, B2C, and marketplace business model to offer at-home blood collection services, making diagnostic testing more accessible and less time-consuming.

By lowering the barriers to regular health monitoring, uPacjenta facilitates early intervention and supports the broader shift toward proactive health management. The startup secured nearly €4.7 million in seed funding, underscoring the market's demand for decentralised diagnostic services.

16. Jakub Zielinski and the Mental Wellness Platform Mindgram

Jakub Zielinski founded Mindgram in 2021 as a comprehensive science-based platform for mental wellness in the workplace. Mindgram provides employees with access to psychologists, psychotherapists, and mental health resources through a mobile app. The company secured $7.7 million in seed funding led by Market One Capital, reflecting the rapid prioritisation of mental health as a core component of corporate wellness and HealthTech infrastructure.

17. Piotr Sosnowski and the Metabolic Focus of Holi

Piotr Sosnowski and Kuba Koziej are the leaders behind Holi, a HealthTech startup dedicated to metabolic health management. Holi provides a structured treatment process that integrates medical monitoring, e-prescriptions, and educational resources, particularly focusing on the rising demand for obesity management and metabolic optimisation.

With over 2,500 patients served and €3.5 Million in funding, Holi represents the "TechBio" approach to chronic disease management, where software serves as the delivery mechanism for complex medical protocols.

18. Patrycja Brzozowska and the Personalized Protocols of Mos Health

Patrycja Brzozowska, alongside co-founders Paweł Chrzan and Paweł Sobkowiak, launched Mos Health to deliver personalised health protocols through an AI-driven platform. Mos Health analyzes user-provided data, lab results, and wearable device data to generate interventions focused on energy, sleep, and nutrition.

In early 2026, the Polish-American company raised $1.1 million in a pre-seed round led by SMOK Ventures and Movens Capital. Brzozowska’s goal is to build a "digital partner" that guides users step-by-step through health optimizations, initially targeting the U.S. and Polish employer benefit markets.

19. Michał Kaczor and the Software Benchmarking of Gralio.ai

Michał Kaczor, CEO and co-founder of Gralio.ai, is building a critical infrastructure tool that assists medical and business professionals in navigating the increasingly complex HealthTech software market. Gralio.ai uses AI models and web bots to analyze thousands of product reviews and user experiences, creating impartial, "apples-to-apples" comparisons of software tools.

As HealthTech becomes "bedrock infrastructure," Kaczor’s platform ensures that healthcare providers can find, compare, and choose the right AI-driven tools for their unique needs, bringing order to a chaotic marketplace.

20. Michal Czyz and the Respiratory Management of FindAir

Michal Czyz founded FindAir in 2016 to digitize the management of asthma and COPD. FindAir’s smart inhaler devices and mobile app provide patients and doctors with real-time data on medication usage and environmental triggers. By combining IoT hardware with sophisticated data analytics, Czyz has created a system that improves patient compliance and allows for more precise adjustments to treatment plans, representing the future of "connected respiratory care".

Market Context and Structural Dynamics

The individual successes of these 20 leaders are part of a broader "tale of two markets" occurring within the Polish and European digital health space. On one hand, AI-native upstarts like Ingenix and AILIS are attracting substantial rounds at unprecedented speeds; on the other, established players are becoming the "core infrastructure" that incumbents rely on to navigate digital transformation.

Venture Capital and Institutional Support

The funding landscape for Polish HealthTech is increasingly characterized by "mega-deals" and the entry of global "Goliath" investors such as Andreessen Horowitz and General Catalyst into the broader European market. Locally, funds like Inovo.vc, OTB Ventures, and Market One Capital have been instrumental in backing the current generation of leaders.

Entity	Role	Impact on HealthTech
Future Tech Poland	€350M Fund-of-Funds	Provides liquidity for early and growth-stage tech startups.
Inovo.vc	Early-stage VC	Lead investor in Ingenix, Jutro Medical, and Quantia.
BGK / EIF	Institutional LPs	Creating the national "Innovate Poland" program to boost CEE competitiveness.
PARP (FENG)	Grant Provider	Funding deep-tech breakthroughs like i4hv's heart valves.

Second-Order Implications of AI Dominance

The massive integration of AI into Polish startups is no longer just a vertical focus but an infrastructure layer. This transition has several profound effects:

Commoditisation of Software Creation: As AI drives the marginal cost of coding toward zero, the "defensible moat" for HealthTech leaders shifts from proprietary software to network effects and unique, high-quality datasets.
Agentic AI in Healthcare: We are entering an era of "Agentic AI," where autonomous agents handle supply-side tasks like vetting medical records, scheduling, and brokering, thereby improving platform liquidity and efficiency.
The Clinical "GPT Moment": The pharmaceutical industry’s traditional R&D model is being challenged by foundational models that can reason across multiple biological scales, potentially making drug development a predictable engineering task rather than a game of chance.

Future Outlook: The Path Toward 2030

The Polish MedTech sector is entering a phase of decentralised growth, with Kraków emerging as a global leader in DeepTech and life sciences while Warsaw remains the financial and software hub. The success of current leaders depends on their ability to navigate the increasingly demanding regulatory environment, particularly CE certification for medical AI and the evolving ISO 13485 standards.

Strategic partnerships between startups and traditional IT giants like Asseco Poland, Comarch and Netguru, who remain the top IT partners for the Polish health sector, will be crucial for scaling these innovations into the broader public health system.

As these 20 leaders continue to validate their models clinically and commercially, the Polish HealthTech renaissance is poised to redefine not only the domestic medical landscape but also the standards of care across the European and global markets.

The transition from "fee-for-service" to "fee-for-health," driven by early detection, personalised simulation, and remote monitoring, represents the ultimate strategic objective for the Polish innovators of 2026 and beyond.

Nelson Advisors > European MedTech and HealthTech Investment Banking

Nelson Advisors specialise in Mergers and Acquisitions, Partnerships and Investments for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies. www.nelsonadvisors.co.uk

Nelson Advisors regularly publish Thought Leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital

Nelson Advisors publish Europe’s leading HealthTech and MedTech M&A Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb

Nelson Advisors pride ourselves on our DNA as ‘Founders advising Founders.’ We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk

#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #SeriesA #SeriesB #Founders #SellSide #TechAssets #Fundraising #BuildBuyPartner #GoToMarket #PharmaTech #BioTech #Genomics #MedTech